Literature DB >> 2744851

Fibrinogen-binding protein/clumping factor from Staphylococcus aureus.

M K Bodén1, J I Flock.   

Abstract

The binding of staphylococcal components to fibrinogen was studied. Fibrinogen-binding material from lysed staphylococcal cells or culture supernatants was affinity purified on fibrinogen-Sepharose and analyzed on Western (immuno-) blots by the use of fibrinogen and antifibrinogen antibodies. Two main bands of 87 and 19 kilodaltons (kDa) and a weaker band of 35 kDa bound specifically to fibrinogen. A monoclonal antibody bound to all three bands, indicating that these were of the same origin. The yield of these components was much higher in the culture supernatant than on washed cells, suggesting that these molecules are essentially extracellular products. In a plasma coagulase test, the 87-kDa band, but not the 19-kDa band, clotted rabbit plasma, demonstrating that the 87-kDa molecule is coagulase. This was further confirmed by the fact that the 87-kDa band binds specifically to prothrombin. It was shown that the 87- and the 19-kDa molecules were present on the cell surface by surface labeling the cells with 125I. In addition, the fact that killed and washed cells could induce plasma clotting demonstrates that staphylococci have coagulase exposed on the surface. It was concluded that cell-bound coagulase has affinity for fibrinogen also in the absence of prothrombin and thus is responsible for the clumping of staphylococci in fibrinogen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744851      PMCID: PMC313455          DOI: 10.1128/iai.57.8.2358-2363.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Evidence for two forms of staphylococcal coagulase.

Authors:  E S DUTHIE
Journal:  J Gen Microbiol       Date:  1954-06

2.  Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli.

Authors:  G S Chhatwal; K T Preissner; G Müller-Berghaus; H Blobel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

3.  Production and properties of Staphylococcus aureus (strain Newman D2C) with uniform clumping factor activity.

Authors:  K D Miller; D L Hetrick; D J Bielefeldt
Journal:  Thromb Res       Date:  1977-02       Impact factor: 3.944

4.  The use of glucose oxidase as a generator of H 2 O 2 in the enzymatic radioiodination of components of cell surfaces.

Authors:  I Schenkein; M Levy; J W Uhr
Journal:  Cell Immunol       Date:  1972-11       Impact factor: 4.868

5.  Comparison of staphylococcal clumping factor and protein A.

Authors:  R Blackstock; F C Kelly
Journal:  J Bacteriol       Date:  1968-09       Impact factor: 3.490

6.  Precipitation of soluble fibrin monomer complexes SFMC by cellular basic proteins, and the antagonistic effect of sulfonated mycopolysaccharides.

Authors:  M Kopec; Z Wegrzynowicz; Z S Latallo
Journal:  Proc Soc Exp Biol Med       Date:  1970-12

7.  Factors involved in experimental staphylococcal peritonitis.

Authors:  F A Kapral
Journal:  Ann N Y Acad Sci       Date:  1965-07-23       Impact factor: 5.691

8.  [Isolation of "clumping factor" of Staphylococcus aureus (author's transl)].

Authors:  J Brückler; W Schaeg; H Blobel
Journal:  Zentralbl Bakteriol Orig A       Date:  1974-09

9.  On the nature of albumin-promoted coagulase release by Staphylococcus aureus.

Authors:  R A Altenbern
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

10.  Influence of lysozyme on aggregation of Staphylococcus aureus.

Authors:  M R Millar; T Inglis
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

View more
  27 in total

1.  Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.

Authors:  M E Dominiecki; J Weiss
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Bacterial infection of wounds: fibronectin-mediated adherence group A and C streptococci to fibrin thrombi in vitro.

Authors:  G S Chhatwal; P Valentin-Weigand; K N Timmis
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Authors:  Ilse Jongerius; Brandon L Garcia; Brian V Geisbrecht; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

4.  Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.

Authors:  Eric L Brown; Yasuhiro Nishiyama; Jesse W Dunkle; Shreya Aggarwal; Stephanie Planque; Kenji Watanabe; Keri Csencsits-Smith; M Gabriela Bowden; Sheldon L Kaplan; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

5.  Functional studies of a fibrinogen binding protein from Staphylococcus epidermidis.

Authors:  L Pei; M Palma; M Nilsson; B Guss; J I Flock
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

6.  Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii.

Authors:  P Stutzmann Meier; J M Entenza; P Vaudaux; P Francioli; M P Glauser; P Moreillon
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity.

Authors:  M Palma; A Haggar; J I Flock
Journal:  J Bacteriol       Date:  1999-05       Impact factor: 3.490

8.  Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis.

Authors:  P Moreillon; J M Entenza; P Francioli; D McDevitt; T J Foster; P François; P Vaudaux
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor.

Authors:  D McDevitt; P Vaudaux; T J Foster
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Binding of heparan sulfate to Staphylococcus aureus.

Authors:  O D Liang; F Ascencio; L A Fransson; T Wadström
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.